Song Bong Gun, Chung Sang Man, Kim Sung Hea, Kim Hyun Joong, Kang Gu Hyun, Park Yong Hwan, Chun Woo Jung, Oh Ju Hyeon
Department of Cardiology, Konkuk University Medical Center; Seoul-Korea.
Anadolu Kardiyol Derg. 2014 Mar;14(2):162-9. doi: 10.5152/akd.2013.4745. Epub 2014 Jan 14.
There are few data regarding clinical characteristics, laboratory parameters, electrocardiographic and echocardiographic findings in takotsubo cardiomyopathy patients presenting with QT prolongation. Aim of this study was to investigate the differences in these parameters between takotsubo cardiomyopathy patients presenting with and those without QT prolongation.
We performed an observational retrospective study. One hundred five patients were enrolled from the takotsubo cardiomyopathy registry database and divided according to the presence of QT prolongation. Fifty patients presented with QT prolongation (QT group) and 55 did not (NQT group). Statistical analysis was performed using Student's t-test or Mann-Whitney U test and chi-square test.
QT group had higher prevalence of dyspnea (66 versus 40%, p=0.008) and cardiogenic shock (46 versus 24%, p=0.016) than NQT group. QT group had higher prevalence of ST elevation (82 versus 64%, p=0.036), T wave inversion (96 versus 58%, p=0.001), ventricular tachycardia/ventricular fibrillation (8 versus 0%, p=0.032) and classic ballooning pattern (92 versus 66%, p=0.003), but lower left ventricular ejection fraction (mean, 39.2 versus 43.5%, p=0.005). In addition, QT group had significant higher hs-C-reactive protein (median, 6.6 versus 1.7 mg/L, p=0.023), creatine kinase-MB (median, 18.6 versus 7.6 ng/mL, p=0.032) and NT-pro-brain natriuretic peptide levels (median, 3637 versus 2145 pg/mL, p=0.044). QT group required more frequent use of inotropics (46 versus 24%, p=0.016) and diuretics (58 versus 38%, p=0.042) than NQT group.
The clinical features of takotsubo cardiomyopathy are different according to the presence of QT prolongation. The QT group was lesser likely to have preserved cardiovascular reserve and more likely to require hemodynamic support than the NQT group despite the entire prognosis of takotsubo cardiomyopathy is excellent regardless of QT prolongation.
关于伴有QT延长的应激性心肌病患者的临床特征、实验室参数、心电图和超声心动图表现的数据较少。本研究的目的是调查伴有QT延长和不伴有QT延长的应激性心肌病患者在这些参数上的差异。
我们进行了一项观察性回顾性研究。从应激性心肌病注册数据库中纳入105例患者,并根据是否存在QT延长进行分组。50例患者伴有QT延长(QT组),55例患者不伴有QT延长(NQT组)。使用Student's t检验或Mann-Whitney U检验以及卡方检验进行统计分析。
QT组呼吸困难(66%对40%,p=0.008)和心源性休克(46%对24%,p=0.016)的患病率高于NQT组。QT组ST段抬高(82%对64%,p=0.036)、T波倒置(96%对58%,p=0.001)、室性心动过速/心室颤动(8%对0%,p=0.032)和经典气球样变模式(92%对66%,p=0.003)的患病率更高,但左心室射血分数更低(平均39.2%对43.5%,p=0.005)。此外,QT组的高敏C反应蛋白(中位数6.6对1.7mg/L,p=0.023)、肌酸激酶同工酶MB(中位数18.6对7.6ng/mL,p=0.032)和N末端脑钠肽前体水平(中位数3637对2145pg/mL,p=0.044)显著更高。QT组比NQT组更频繁使用正性肌力药物(46%对24%,p=0.016)和利尿剂(58%对38%,p=0.042)。
应激性心肌病的临床特征因是否存在QT延长而有所不同。尽管无论QT延长情况如何,应激性心肌病的总体预后良好,但QT组比NQT组更不容易保留心血管储备,更可能需要血流动力学支持。